Table 2. C_max and AUC of triglyceride and blood remnant-like particle cholesterol.

		Parameter	Group	Mean±SD	P value
TG	All subjects	Cmax (mg/dL)	Control	174.1±61.6	0.667
			IMD	169.4±51.9
		AUC0-6hr (mg/dL∙hr)	Control	799.7±291.4	0.978
			IMD	780.5±247.1
		ΔCmax (mg/dL)	Control	84.7±42.2	0.878
			IMD	83.4±36.8
		ΔAUC0-6hr (mg/dL∙hr)	Control	263.2±155.9	0.717
			IMD	264.3±132.7
	Subgroup analysis subjects	Cmax (mg/dL)	Control	237.5±50.2	0.009*
			IMD	192.2±43.1
		AUC0-6hr (mg/dL∙hr)	Control	1115.1±209.9	0.084
			IMD	941.1±256.3
		ΔCmax (mg/dL)	Control	112.4±50.9	0.009*
			IMD	87.7±35.0
		ΔAUC0-6hr (mg/dL∙hr)	Control	364.3±192.3	0.221
			IMD	314.1±173.3
RLP-C	All subjects	Cmax (mg/dL)	Control	7.2±3.5	0.540
			IMD	7.0±2.7
		AUC0-6hr (mg/dL∙hr)	Control	35.2±16.1	0.638
			IMD	34.1±13.9
		ΔCmax (mg/dL)	Control	3.0±2.4	0.857
			IMD	3.0±1.7
		ΔAUC0-6hr (mg/dL∙hr)	Control	9.9±8.6	0.298
			IMD	10.1±7.1
	Subgroup analysis subjects	Cmax (mg/dL)	Control	10.6±3.4	0.067
			IMD	8.7±2.7
		AUC0-6hr (mg/dL∙hr)	Control	51.1±14.8	0.064
			IMD	42.3±15.3
		ΔCmax (mg/dL)	Control	4.7±3.2	0.218
			IMD	3.9±2.1
		ΔAUC0-6hr (mg/dL∙hr)	Control	15.9±11.3	0.683
			IMD	13.6±9.8

Statistical analyses were performed using a Wilcoxon signed-rank test (*p <0.05).

AUC: area under the curve, SD: standard deviation, TG: triglyceride, RLP-C: remnant-like particle cholesterol